| scholarly article | Q13442814 |
| P2093 | author name string | Veronica Mericq | |
| Li Zhu | |||
| Xue Chen | |||
| Gary E Striker | |||
| Helen Vlassara | |||
| Weijing Cai | |||
| Jaime Uribarri | |||
| Cecilia Piccardo | |||
| P2860 | cites work | Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism | Q44582556 |
| Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood | Q45082379 | ||
| Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection | Q46536137 | ||
| Offspring from mothers fed a 'junk food' diet in pregnancy and lactation exhibit exacerbated adiposity that is more pronounced in females | Q46604434 | ||
| Plasma concentration and urinary excretion of N epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants | Q46617590 | ||
| Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake | Q46620647 | ||
| Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress | Q46843335 | ||
| Concentrations of Nepsilon-carboxymethyllysine in human breast milk, infant formulas, and urine of infants | Q80182489 | ||
| Inflammation and insulin resistance | Q22241893 | ||
| Advanced glycation end products in foods and a practical guide to their reduction in the diet | Q24602482 | ||
| Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging | Q24650528 | ||
| Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy | Q34388076 | ||
| Glycoxidation and diabetic complications: modern lessons and a warning? | Q35813624 | ||
| Dietary fat, insulin sensitivity and the metabolic syndrome. | Q35857212 | ||
| Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction | Q36088078 | ||
| Prenatal programming of childhood overweight and obesity | Q36606066 | ||
| Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study | Q36756666 | ||
| Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan | Q36778201 | ||
| Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis | Q37210742 | ||
| Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. | Q37417494 | ||
| The accelerating epidemic of childhood diabetes | Q39975293 | ||
| Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. | Q40625908 | ||
| Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. | Q44043194 | ||
| Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice | Q44453007 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2232-2237 | |
| P577 | publication date | 2010-07-13 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? | |
| P478 | volume | 33 |
| Q37003623 | AGE restriction in diabetes mellitus: a paradigm shift |
| Q37520014 | Advanced glycation end products (AGE) and diabetes: cause, effect, or both? |
| Q35227180 | Advanced glycation end products are direct modulators of β-cell function |
| Q34542291 | Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption |
| Q26800114 | Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance |
| Q36963380 | Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children |
| Q60301079 | Dietary advanced glycation end-product consumption leads to mechanical stiffening of murine intervertebral discs |
| Q37591929 | Dietary glycotoxins and infant formulas |
| Q21260349 | Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes |
| Q35902859 | Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study |
| Q38931265 | Long-term metabolic risk among children born premature or small for gestational age. |
| Q36796216 | Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift |
| Q92163626 | Maternal Consumption of a Diet Rich in Maillard Reaction Products Accelerates Neurodevelopment in F1 and Sex-Dependently Affects Behavioral Phenotype in F2 Rat Offspring |
| Q50453950 | Maternal intake of fatty acids and their food sources during lactation and the risk of preclinical and clinical type 1 diabetes in the offspring |
| Q89781565 | Methylglyoxal, Glycated Albumin, PAF, and TNF-α: Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes |
| Q92056715 | Optimization of spray drying parameters and food additives to reduce glycation using response surface methodology in powdered infant formulas |
| Q47575059 | Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction. |
| Q51328426 | Plasma insulin levels in childhood are related to maternal factors--results of the Ulm Birth Cohort Study. |
| Q35539571 | Prenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats. |
| Q38950436 | Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis. |
| Q37635808 | Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother's smoking habits |
| Q30318169 | [Protein glycation as a pathological mechanism in diabetes]. |
Search more.